136 related articles for article (PubMed ID: 8419351)
21. Thrombin generation and inactivation in the presence of antithrombin III and heparin.
Lindhout T; Baruch D; Schoen P; Franssen J; Hemker HC
Biochemistry; 1986 Oct; 25(20):5962-9. PubMed ID: 3790498
[TBL] [Abstract][Full Text] [Related]
22. The effect of heparin on the regulation of factor VIIa-tissue factor activity by tissue factor pathway inhibitor.
Hamamoto T; Kisiel W
Blood Coagul Fibrinolysis; 1996 Jun; 7(4):470-6. PubMed ID: 8840000
[TBL] [Abstract][Full Text] [Related]
23. S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin.
Preissner KT; Müller-Berghaus G
Eur J Biochem; 1986 May; 156(3):645-50. PubMed ID: 3699029
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of activated factor XII by antithrombin-heparin cofactor.
Stead N; Kaplan AP; Rosenberg RD
J Biol Chem; 1976 Nov; 251(21):6481-8. PubMed ID: 61963
[TBL] [Abstract][Full Text] [Related]
25. Purification and properties of human coagulation factor VII.
Broze GJ; Majerus PW
J Biol Chem; 1980 Feb; 255(4):1242-7. PubMed ID: 7354023
[TBL] [Abstract][Full Text] [Related]
26. Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of alpha-thrombin.
Olson ST
J Biol Chem; 1985 Aug; 260(18):10153-60. PubMed ID: 4019506
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of antithrombin III, activated protein C and heparin on the inhibition of the tissue thromboplastin-mediated coagulation.
Hirahara K; Etoh Y; Matsuishi T; Suzuki N; Kurata M
Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):692-6. PubMed ID: 2752479
[TBL] [Abstract][Full Text] [Related]
28. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity.
Sheehan JP; Wu Q; Tollefsen DM; Sadler JE
J Biol Chem; 1993 Feb; 268(5):3639-45. PubMed ID: 8429040
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation.
Pieters J; Willems G; Hemker HC; Lindhout T
J Biol Chem; 1988 Oct; 263(30):15313-8. PubMed ID: 3262615
[TBL] [Abstract][Full Text] [Related]
30. Factor VIIa-Antithrombin complexes during cardiac surgery using cardiopulmonary bypass.
Davidson SJ; Woodhams B
Int J Lab Hematol; 2011 Dec; 33(6):614-6. PubMed ID: 21569219
[TBL] [Abstract][Full Text] [Related]
31. Functional requirements for inhibition of thrombin by antithrombin III in the presence and absence of heparin.
Tsiang M; Jain AK; Gibbs CS
J Biol Chem; 1997 May; 272(18):12024-9. PubMed ID: 9115268
[TBL] [Abstract][Full Text] [Related]
32. Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
Parlow JJ; Case BL; Dice TA; Fenton RL; Hayes MJ; Jones DE; Neumann WL; Wood RS; Lachance RM; Girard TJ; Nicholson NS; Clare M; Stegeman RA; Stevens AM; Stallings WC; Kurumbail RG; South MS
J Med Chem; 2003 Sep; 46(19):4050-62. PubMed ID: 12954058
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
Pedersen AH; Nordfang O; Norris F; Wiberg FC; Christensen PM; Moeller KB; Meidahl-Pedersen J; Beck TC; Norris K; Hedner U
J Biol Chem; 1990 Oct; 265(28):16786-93. PubMed ID: 2211593
[TBL] [Abstract][Full Text] [Related]
34. Kinetic analysis of the heparin-enhanced plasmin--antithrombin III reaction. Apparent catalytic role of heparin.
Machovich R; Bauer PI; Arányi P; Kecskés E; Büki KG; Horváth I
Biochem J; 1981 Dec; 199(3):521-6. PubMed ID: 6462134
[TBL] [Abstract][Full Text] [Related]
35. Interaction of factor Xa with heparin does not contribute to the inhibition of factor Xa by antithrombin III-heparin.
Owen BA; Owen WG
Biochemistry; 1990 Oct; 29(40):9412-7. PubMed ID: 2248954
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in the discovery of tissue factor/factor VIIa inhibitors and dual inhibitors of factor VIIa/factor Xa.
Kranjc A; Kikelj D; Peterlin-Masic L
Curr Pharm Des; 2005; 11(32):4207-27. PubMed ID: 16375741
[TBL] [Abstract][Full Text] [Related]
37. The relative molecular mass dependence of the anti-factor Xa properties of heparin.
Ellis V; Scully MF; Kakkar VV
Biochem J; 1986 Sep; 238(2):329-33. PubMed ID: 3800942
[TBL] [Abstract][Full Text] [Related]
38. Involvement of heparin chain length in the heparin-catalyzed inhibition of thrombin by antithrombin III.
Hoylaerts M; Owen WG; Collen D
J Biol Chem; 1984 May; 259(9):5670-7. PubMed ID: 6715365
[TBL] [Abstract][Full Text] [Related]
39. Calcium inhibits the heparin-catalyzed antithrombin III/thrombin reaction by decreasing the apparent binding affinity of heparin for thrombin.
Speight MO; Griffith MJ
Arch Biochem Biophys; 1983 Sep; 225(2):958-63. PubMed ID: 6625618
[TBL] [Abstract][Full Text] [Related]
40. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
